Manufacturer record

Paradox Pharmaceuticals: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Paradox Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between May 2025 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Paradox Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2025 to May 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2025
3
Products affected
Assay
Most common failure
May 2025
Latest alert

Flagged batches per year

2025 · 4

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Pantoprazole Gastro resistant &Domperidone prolonged release Capsules IP PZD242206Mfg 2025-01 · Exp 2026-12 Identification and Assay of Pantoprazole Sodium calculated as Pantoprazole and Domperidone and the Dissolution of Pantoprazole Sodium calculated as Pantoprazle.Assay RDTL, ChandigarhCDSCO lab May 2025
Azithromycin Tablets IP 250 mg (RICK-250 TABLETS) Not mentionedMfg ? · Exp ? Identification, Dissolution and Assay of Azithromycin Dihydrate Calculated as Anhydrous AzithromycinAssay RDTL, ChandigarhCDSCO lab May 2025
Azithromycin Tablets IP 250 mg (RICK-250 TABLETS) AZR2411010Mfg 2025-01 · Exp 2026-12 Identification, Dissolution and the Assay of AzithromycinAssay RDTL, ChandigarhCDSCO lab May 2025
Amoxycillin and Potassium Clavulanate with Lactic Acid Bacillus Tablets (Polo-625 LB Tablets) PL2406001Mfg 2024-10 · Exp 2026-11 Identification and Assay of Amoxycillin Trihydrate, Potassium Clavulanate and Lactic Acid BacillusAssay RDTL, ChandigarhCDSCO lab May 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.